Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Familial Cancer

• Publication date

  2007-07-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10689-007-9151-yPMID 17636424
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of BRCA1 and BRCA2 Mutation Prevalence, Risk Prediction Models and a Multi-Step Testing Approach in French-Canadian High-Risk Breast and/or Ovarian Cancer Families

  2007influential reference
• Common Genetic Variation at PTEN and Risk of Sporadic Breast and Prostate Cancer

  2006cited by this paper
• Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

  2006cited by this paper
• Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer

  2006cited by this paper
• Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families

  2006cited by this paper
• Different splicing defects lead to differential effects downstream of the lipid and protein phosphatase activities of PTEN.

  2005cited by this paper
• Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families

  2005cited by this paper
• Genomic variants in exons and introns: identifying the splicing spoilers

  2004cited by this paper
• CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.

  2004cited by this paper
• PTEN mutations are common in sporadic microsatellite stable colorectal cancer

  2004cited by this paper
• Multiple sequence alignment with the Clustal series of programs

  2003cited by this paper
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003cited by this paper
• Germline mutations in the PTEN gene in Israeli patients with Bannayan–Riley–Ruvalcaba syndrome and women with familial breast cancer

  2002cited by this paper
• Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas

  2002cited by this paper
• CCND1‐ and ERBB2‐gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast

  2002cited by this paper
• Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.

  2001cited by this paper
• Breast cancer, Cowden disease and PTEN-MATCHS syndrome.

  2001cited by this paper
• GeneSplicer: a new computational method for splice site prediction.

  2001cited by this paper
• A computational analysis of sequence features involved in recognition of short introns

  2001cited by this paper
• Loss of Expression of the PTEN Gene Protein Product Is Associated with Poor Outcome in Breast Cancer

  2001cited by this paper
• The expression profile for the tumour suppressor gene PTEN and associated polymorphic markers

  2000cited by this paper
• Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast.

  1999cited by this paper
• Linkage analysis of 56 multiplex families excludes the Cowden disease genePTEN as a major contributor to familial breast cancer

  1999cited by this paper
• PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.

  1999cited by this paper
• Mutation analysis of the putative tumor suppression gene PTEN/MMAC1 in sporadic breast cancer

  1999cited by this paper
• Polymorphisms in PTEN in breast cancer families

  1999cited by this paper
• Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas

  1998cited by this paper
• PTEN germ-line mutations in juvenile polyposis coli

  1998cited by this paper
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

  1998cited by this paper
• Infrequent Genetic Alterations of the PTEN/MMAC1 Gene in Japanese Patients with Primary Cancers of the Breast, Lung, Pancreas, Kidney, and Ovary

  1997cited by this paper
• MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.

  1997cited by this paper
• Improved Splice Site Detection in Genie

  1997influential reference
• Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.

  1997cited by this paper
• PTEN1 is frequently mutated in primary endometrial carcinomas

  1997cited by this paper
• Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis.

  1997cited by this paper
• Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project.

  1990influential reference
• RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression.

  1987influential reference

• Comparative analysis of functional assay evidence use by ClinGen Variant Curation Expert Panels

  2019cites this paper
• Breast cancer genetic susceptibility: With focus in Saudi Arabia

  2019cites this paper
• Genetic Risk Prediction in Breast Cancer

  2018cites this paper
• Association of Single-Nucleotide Polymorphisms in Monoubiquitinated FANCD2-DNA Damage Repair Pathway Genes With Breast Cancer in the Chinese Population

  2018cites this paper
• Translational opportunities for broad‐spectrum natural phytochemicals and targeted agent combinations in breast cancer

  2018cites this paper
• Evaluation of the association between common genetic variants and breast cancer risk

  2017cites this paper
• Targeting PI3K/AKT/mTOR Pathway

  2017cites this paper
• A Novel Function for FANCJ Helicase In Microsatellite Stabilization During Replication Stress

  2015cites this paper
• Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum Disorder

  2015cites this paper
• Prioritization of potential candidate disease genes by topological similarity of protein-protein interaction network and phenotype data

  2015influential citation
• ASSESSING THE PRACTICES OF GENETIC COUNSELORS REGARDING HEAD CIRCUMFERENCE MEASUREMENT IN HEREDITARY CANCER ASSESSMENT

  2014cites this paper
• Variation of the PALB 2 and PTEN Genes and eIF 4 E Protein Expression as Prognostic Factors in Breast Cancer

  2013cites this paper
• Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer.

  2013cites this paper
• Association of Phosphatase and Tensin Homolog rs3830675 Gene Polymorphisms and Breast Cancer

  2013cites this paper
• Variation of the PALB2 and PTEN Genes and eIF4E Protein Expression as Prognostic Factors in Breast Cancer

  2013cites this paper
• Variants on the promoter region of PTEN affect breast cancer progression and patient survival

  2011cites this paper
• Genetic changes in the PTEN gene and their association with breast cancer in Pakistan.

  2011cites this paper
• Familial Breast Cancer- Risk populations and their surveillance

  2011cites this paper
• PTEN mutation spectrum in breast cancers and breast hyperplasia

  2010cites this paper
• PTEN polymorphism (IVS4) in breast cancer in Iranian women

  2010cites this paper
• Analyse de gènes candidats au cancer du sein impliqués dans les interactions avec BRCA1 et BRCA2

  2010cites this paper
• Beyond BRCA1 and BRCA2 wild‐type breast and/or ovarian cancer families: germline mutations in TP53 and PTEN

  2010cites this paper
• Evaluation of the Contribution of the Three Breast Cancer Susceptibility Genes CHEK2, STK11, and PALB2 in Non-BRCA1/2 French Canadian Families with High Risk of Breast Cancer

  2010cites this paper
• Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian Families with high risk of breast cancer

  2009cites this paper
• Cowden Syndrome: A Critical Review of the Clinical Literature

  2009cites this paper
• Breast cancer susceptibility: current knowledge and implications for genetic counselling

  2009cites this paper
• Genetic risk of breast cancer.

  2009cites this paper
• Other Hereditary Breast Cancer Syndromes and Genes

  2009cites this paper
• Genetic predisposition to breast cancer: past, present, and future.

  2008cites this paper
• Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high‐risk non BRCA1/2 French Canadian breast and ovarian cancer families

  2008cites this paper
• Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families

  2008cites this paper
• Screening of coding region of metastasis suppressor genes KISS1 and KAI-1 for germ line mutations in breast cancer patients

  2008cites this paper
• Genetic sequence variations and ADPRT haplotype analysis in French Canadian families with high risk of breast cancer

  2007cites this paper
• Award Number: W81XWH-05-1-0204 TITLE: Identification, Characterisation and Clinical Development of the New General of Breast Cancer Susceptibility Alleles

  2007cites this paper
• The Application of Clinical Genetics Dovepress Genetic Basis of Cowden Syndrome and Its Implications for Clinical Practice and Risk Management

  year unknowncites this paper